These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6223765)
21. [Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients]. Giacchino F; Giachino G; Giraudo G; Boero R; Basolo B; Bancale E; Nigra M; Piccoli GB; Piccoli G Arch Sci Med (Torino); 1982; 139(1):19-22. PubMed ID: 7103704 [TBL] [Abstract][Full Text] [Related]
22. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kurz P; Köhler H; Meuer S; Hütteroth T; Meyer zum Büschenfelde KH Kidney Int; 1986 Jun; 29(6):1209-14. PubMed ID: 3489122 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic and proliferative responses of human thoracic duct lymphocytes: effect of thoracic duct drainage in uremic patients. Cordier G; Brochier J; Revillard JP Clin Immunol Immunopathol; 1976 May; 5(3):351-9. PubMed ID: 1277591 [No Abstract] [Full Text] [Related]
24. Derangement of humoral immune system in nondialyzed uremic patients. Kamata K; Okubo M Jpn J Med; 1984 Feb; 23(1):9-15. PubMed ID: 6379244 [TBL] [Abstract][Full Text] [Related]
25. Induction of suppressor cell activity by cyclosporin A and/or uremic serum in normal versus uremic peripheral blood mononuclear cells. Modai D; Berman S; Cohen D; Amit M; Cohn M; Weissgarten J; Averbukh Z Int Arch Allergy Appl Immunol; 1990; 91(3):291-6. PubMed ID: 2141326 [TBL] [Abstract][Full Text] [Related]
27. [Further investigations on cellular immunodeficiency in uraemic patients and the effect of haemodialysis (author's transl)]. Reis HE; Cremer W; Heimsoth VH; Graffe-Achelis C; Wetter O Klin Wochenschr; 1975 May; 53(10):467-72. PubMed ID: 1195651 [TBL] [Abstract][Full Text] [Related]
28. Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation. Dumann H; Meuer SC; Köhler H Nephron; 1990; 56(2):162-5. PubMed ID: 2243571 [TBL] [Abstract][Full Text] [Related]
29. T lymphocyte subsets in chronic uremic patients treated with maintenance hemodialysis. Morra L; Ponassi GA; Gurreri G; Moccia F; Mela GS; Bessone G Biomed Pharmacother; 1990; 44(1):53-6. PubMed ID: 1369694 [TBL] [Abstract][Full Text] [Related]
30. Immune response in experimentally induced uremia. III. Uremic adherent spleen cells are defective in their ability to act as stimulators in mixed-leukocyte culture. Alevy YG; Slavin RG Clin Immunol Immunopathol; 1982 Aug; 24(2):227-38. PubMed ID: 6214355 [No Abstract] [Full Text] [Related]
31. Serial cell-mediated immunological changes in terminal uremic patients on continuous ambulatory peritoneal dialysis therapy. Lin CY; Huang TP Am J Nephrol; 1988; 8(5):355-62. PubMed ID: 2977061 [TBL] [Abstract][Full Text] [Related]
32. The CD8+ Leu-7+ subset of T cells in Crohn's disease: distinction between cytotoxic and covert suppressor functions. Deem RL; Targan SR; Niederlehner A; Shanahan F Clin Exp Immunol; 1990 Jun; 80(3):387-94. PubMed ID: 1695560 [TBL] [Abstract][Full Text] [Related]
33. Analysis of humoral and cellular factors that contribute to impaired immune responsiveness in experimental uremia. Mezzano S; Pesce AJ; Pollak VE; Michael JG Nephron; 1984; 36(1):15-9. PubMed ID: 6606788 [TBL] [Abstract][Full Text] [Related]
35. Depressed immune response in burn patients: use of monoclonal antibodies and functional assays to define the role of suppressor cells. McIrvine AJ; O'Mahony JB; Saporoschetz I; Mannick JA Ann Surg; 1982 Sep; 196(3):297-304. PubMed ID: 6214221 [TBL] [Abstract][Full Text] [Related]
36. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors. Schmid DS; Rouse BT J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080 [TBL] [Abstract][Full Text] [Related]